You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daratumumab

Showing 251 - 273 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (DARATUMUMAB, DURVALUMAB)

Completed
Has Results
  • Multiple Myeloma
  • Duarte, California
  • +24 more
Sep 18, 2018

Multiple Myeloma Trial in Netherlands (Iberdomide plus low-dose cyclophosphamide and dexamethasone)

Recruiting
  • Multiple Myeloma
  • Iberdomide plus low-dose cyclophosphamide and dexamethasone
  • Alkmaar, Netherlands
  • +8 more
Oct 5, 2021

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Multiple Myeloma Trial in Canada, Spain, United States (Daratumumab 16 mg/kg (Part 1), Daratumumab 8 mg/kg (Part 1),

Completed
Has Results
  • Multiple Myeloma
  • Daratumumab 16 mg/kg (Part 1)
  • +5 more
  • Duarte, California
  • +22 more
Jun 21, 2018

Immune Profiling in Multiple Myeloma

Recruiting
  • Multiple Myeloma
    • Torino, TO, Italy
      Aou Citta' Della Salute E Della Scienza Di Torino
    Apr 28, 2021

    Multiple Myeloma Trial in Worldwide (Part 1: Daratumumab, Part 2: Daratumumab, Methylprednisolone)

    Completed
    Has Results
    • Multiple Myeloma
    • Part 1: Daratumumab
    • +3 more
    • Boston, Massachusetts
    • +6 more
    Mar 30, 2018

    Multiple Myeloma Trial in Galway (Daratumumab, Cyclophosphamide, Bortezomib)

    Unknown status
    • Multiple Myeloma
    • Daratumumab
    • +3 more
    • Galway, Ireland
      Galway University Hospital
    Mar 27, 2018

    Investigate eNAMPT in Multiple Myeloma Biology and Establish Its

    Recruiting
    • Multiple Myeloma
      • Torino, TO, Italy
        Aou Citta' Della Salute E Della Scienza Di Torino
      Aug 17, 2021

      Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

      Not yet recruiting
      • Multiple Myeloma
      • Frailty
        • (no location specified)
        Oct 30, 2023

        Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia Trial in Minsk (Vaccination with pneumococcal conjugate vaccine

        Enrolling by invitation
        • Multiple Myeloma
        • +3 more
        • Vaccination with pneumococcal conjugate vaccine (PCV13)
        • Standard Antibacterial Prophylaxis
        • Minsk, Belarus
          Minsk Scientific Practical Center of Surgery, Transplantation an
        Sep 1, 2020

        Lymphoma, Mantle-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in Worldwide (Daratumumab)

        Terminated
        Has Results
        • Lymphoma, Mantle-Cell
        • +2 more
        • Daratumumab
        • Duarte, California
        • +34 more
        May 28, 2018

        Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Moscow (Preparative regimen)

        Recruiting
        • Refractory Acute Myeloid Leukemia
        • Refractory Acute Lymphoblastic Leukemia
        • Preparative regimen
        • Moscow, Russian Federation
          Dmitry Rogachev National Research Center of Pediatric Hematology
        Nov 19, 2020

        Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

        Withdrawn
        • Amyloidosis
        • Light Chain (AL) Amyloidosis
        • (no location specified)
        Dec 29, 2022

        Multiple Myeloma Trial in Athens (Daratumumab)

        Unknown status
        • Multiple Myeloma
        • Daratumumab
        • Athens, Attica, Greece
          General Hospital of Athens "Alexandra"
        Feb 22, 2018

        Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)

        Recruiting
        • Relapsed Multiple Myeloma
        • Belantamab mafodotin
        • +2 more
        • Badalona, Spain
        • +14 more
        Sep 5, 2022

        Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)

        Active, not recruiting
        • Smoldering Multiple Myeloma
        • Barcelona, Spain
        • +15 more
        Feb 15, 2021

        Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

        Active, not recruiting
        • Multiple Myeloma
        • Myeloma
        • Poitiers, France
          CHU Poitiers
        Sep 5, 2022

        Melanoma Trial in United States (Ipilimumab, Nivolumab)

        Completed
        Has Results
        • Melanoma
        • Duarte, California
        • +35 more
        Sep 8, 2021

        Multiple Myeloma Trial in Vejle (Daratumumab, Lenalidomide, Dexamethasone)

        Completed
        • Multiple Myeloma
        • Daratumumab
        • +2 more
        • Vejle, Denmark
          Department of Hematology Vejle Hospital
        Nov 6, 2017

        Multiple Myeloma Trial in United States (Pomalidomide, Bortezomib, Dexamethasone)

        Completed
        • Multiple Myeloma
        • Atlanta, Georgia
        • +5 more
        Apr 3, 2020

        Malignant Tumors of Male Genital Organs, Prostate Cancer Trial (Daratumumab)

        Withdrawn
        • Malignant Neoplasms of Male Genital Organs
        • Prostate Cancer
        • Daratumumab
        • (no location specified)
        Apr 20, 2017

        Multiple Myeloma in Relapse Trial in Changchun (Clarithromycin Lenalidomide Dexamethasone (BiRd) Regimen)

        Unknown status
        • Multiple Myeloma in Relapse
        • Clarithromycin Lenalidomide Dexamethasone (BiRd) Regimen
        • Changchun, Jilin, China
          The First Hospital of Jilin University
        Aug 17, 2019

        Multiple Myeloma Trial in Nagoya, Tokyo (Daratumumab)

        Completed
        • Multiple Myeloma
        • Daratumumab
        • Nagoya, Japan
        • +1 more
        Sep 23, 2016